The president said his tariffs would range from 25 to 100 percent and would go into effect next week.
Category: United States Politics and Government
-
Trump Wades Into Bailout Politics in Offering a Lifeline to Argentina
A $20 billion loan to support Argentina’s president, Javier Milei, could come with economic and political risks.
-
Top Economic Leaders Warn Supreme Court to Allow Lisa Cook to Remain at Fed, for Now
In a brief filed with the court, former Fed chairs and U.S. Treasury secretaries cautioned of erosion in public confidence in the Fed’s independence.
-
Princess Awesome vs. the United States of America
A children’s clothing company has become the face of a legal battle over President Trump’s trade policy, after years of struggling with the challenges of domestic manufacturing.
-
Princess Awesome vs. the United States of America
A children’s clothing company has become the face of a legal battle over President Trump’s trade policy, after years of struggling with the challenges of domestic manufacturing.
-
A Federal Shutdown May Be Imminent. How Would It Affect the Economy?
Congress and the White House have days to fund the government and avert a disruptive and potentially costly lapse in funding.
-
Why Obamacare Bills May Double Next Year
Extensive subsidies that reduce premium costs for millions are set to expire, unless Congress extends them.
-
Why Obamacare Bills May Double Next Year
Extensive subsidies that reduce premium costs for millions are set to expire, unless Congress extends them.
-
How to Watch Jimmy Kimmel’s Return Tonight if Your ABC Station Isn’t Airing It
The show is coming back after backlash from comments Mr. Kimmel made on air last week. But not everyone will be able to view the episode live.
-
How to Watch ‘Jimmy Kimmel Live!’ if Your Station Isn’t Airing the Show
The show is coming back after backlash from comments Mr. Kimmel made on air last week. But not everyone will be able to view the episode live.
-
F.D.A.’s Approval of Drug for Autism Upends Review Process
The agency revived an old treatment for cancer patients, unilaterally approving it for a subset of people with autism. Experts worry that the narrower scope will get lost in the hype.